We observed significantly lower mRNA expression of NR5A2 in the majority of pancreatic tumors and cell lines tested compared with histologically normal pancreatic tissue samples, indicating a possible role for reduced NR5A2 expression in pancreatic cancer. Here, NR5A2 is linked to familial pancreatic carcinoma.